Aperiam Bio: Funding, Investors & Team (Sep 2026)
Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States.
Aperiam Bio has raised $16.7M across 3 funding rounds on record, the most recent a Seed of $9.0M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aperiam Bio Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Aperiam Bio Funding Rounds
Aperiam Bio raised $3.7M in a Seed announced in Mar 2022.
1.5 years later, a Seed of $4.0M was announced in Sep 2023.
2 months later, a Seed of $9.0M was announced in Nov 2023.
Aperiam Bio Founders and Leadership Team
Contact details for the Aperiam Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Aperiam Bio Funding Compared to Other Biotechnology Startups
Aperiam Bio's latest round of $9.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aperiam Bio in Biotechnology and Austin
Companies Similar to Aperiam Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Aperiam Bio Funding FAQs
What does Aperiam Bio do?
Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States.
How much funding has Aperiam Bio raised?
Aperiam Bio has raised $16.7M across 3 rounds on record. The most recent is a Seed of $9.0M announced in Nov 2023.
When did Aperiam Bio last raise funding?
Aperiam Bio's most recent funding round on record is a Seed of $9.0M, announced in Nov 2023.
Who is the CEO of Aperiam Bio?
Austin Cole is listed as CEO at Aperiam Bio.
Where is Aperiam Bio headquartered?
Aperiam Bio is based in Austin, Texas, United States.
How many employees does Aperiam Bio have?
Aperiam Bio is in the 1-10 employee band.
How does Aperiam Bio's funding compare to other Biotechnology startups?
Aperiam Bio's latest round of $9.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aperiam Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aperiam Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.